In 1970, about 10000 people living in Tari in the southern highlands of Papua New Guinea were placed under household surveillance in order to study morbidity and mortality rates from acute lower respiratory tract infection (ALTRI). In 1973, a trial of a 14-valent pneumococcal polysaccharide vaccine in persons aged at least 10 years showed fewer confirmed pneumococcal infections in the vaccine group; the vaccine was also effective in preventing death from pneumonia.' ALRTI constitutes an even greater health problem in children in Papua New Guinea than it does in adults. This paper reports details of morbidity 
Materials and methods
Study area and population. The Tari basin is an isolated region in the western third of the Southern Highlands Province and lies at an altitude of between 5000 and 6000 feet. The inhabitants, the Huli people, are mainly subsistence farmers whose staple crop is the sweet potato. In mid-1973, 10 260 people were under surveillance for ALRTI, and of these, 3023 were children under age 10. The yearly infant mortality rate was 72 per 1000; mortality in children aged between 1 and 4 years was 16 per 1000; and in children aged between 5 and 9 years it was 3 per 1000. ALRTI was the main cause of death in children, followed by enteritis necroticans, gastroenteritis, and dysentery. Health services in the study area were adequate: oxygen and a range of antibiotics could be obtained from the hospital and the two healthcentres, and procaine penicillin could be obtained from the three aid-posts. These health services were well used and 61 % of infants under age 1 year, and 70 % of children aged between 1 and 4 years had had treatment in the course of terminal illnesses.
Minor degrees of malnutrition are not uncommon in Tari. Median weight for age declines from 96% of the Harvard standard2 in the first 6 months of life to 85 % in the second 6 
Effects of immunisation. No side effects were reported in the 43 children injected with known vaccine, and whose mothers were directly questioned about side effects. Later, the mothers of children who participated in the double-blind trial were asked to report side effects. None did so.
Altogether 871 children, aged between 6 and 59 months at the time of vaccination, were studied. Their distribution by year of birth is shown in Table 2 .
The total number of attacks of ALRTI, distributed by year of birth of the children, is also shown in Table 2 . The vaccine seems to have been effective in preventing ALRTI in children born before 1973, but not in children born in 1973 or 1974. Among the former (who were at least 17 months of age at the time of vaccination) there were 74 cases in the placebo group, and 39 in the vaccine group; the vaccine was 37% effective (P = 0 010, 95% confidence for lower limit of effectiveness = 12 %). possible that the effect in children was similar to that in adults in the earlier trial in Tari when the vaccine had a greater effect on the severity than on the incidence of disease.
Deaths occurred in Tari despite the widespread availability of antibiotics, and the limited availability of oxygen. Although curative health services in Papua New Guinea hav.-undoubtedly had a striking effect upon mortality in the years since the second world war,'" the results from this trial suggest that further reduction in mortality from ALRTI will be best achieved by the use of vaccines, rather than by improvements in curative services.
A trial of larger scale, with continuous entry of children and with good laboratory support, is clearly needed. 
